Real world outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177-PSMA-vipivotide tetraxetan (Lu177-PVT).
| Autor: | Bergstrom, Colin P, Song, Hong, Ruiz, Shann Mika, Chien, Joanne, Moore, Kaidi, Parikh, Divya Ahuja, Shah, Sumit, Fan, Alice C., Srinivas, Sandy, Iagaru, Andrei, Khaki, Ali Raza |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p86-86, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|